Page last updated: 2024-08-21

eosine yellowish-(ys) and Epithelial Ovarian Cancer

eosine yellowish-(ys) has been researched along with Epithelial Ovarian Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, M; Huang, X; Liu, J; Shangguan, M; Wang, T; Wu, S; Yang, Z; Zhang, C; Zhao, S1
Boldrini, L; Fagotti, A; Giudice, MT; Inzani, F; Lenkowicz, J; Minucci, A; Nero, C; Pasciuto, T; Piermattei, A; Scambia, G; Valentini, V; Zannoni, G1

Other Studies

2 other study(ies) available for eosine yellowish-(ys) and Epithelial Ovarian Cancer

ArticleYear
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
    Oncology reports, 2022, Volume: 48, Issue:5

    Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Complex Mixtures; Cyclin B1; Cyclin-Dependent Kinase 4; Cyclooctanes; Cysteine; Dioxoles; Eosine Yellowish-(YS); Female; Humans; Lignans; Mice; Ovarian Neoplasms; Oxidative Stress; Paclitaxel; Reactive Oxygen Species

2022
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer.
    International journal of molecular sciences, 2022, Sep-26, Volume: 23, Issue:19

    Topics: BRCA1 Protein; Carcinoma, Ovarian Epithelial; Deep Learning; Eosine Yellowish-(YS); Female; Germ-Line Mutation; Hematoxylin; Humans; Mutation; Ovarian Neoplasms

2022